BioSpace News Archive

Teva Agrees to Pay $54 Million to Settle Allegations that the Company Used Sham Paid Speaker Programs to Increase Use of Copaxone and Azilect

Nebraska Tops the State List While the South Comprises Remainder of Top States and Nearly All Top Markets

A live audio webcast of the presentation and archive for replay will be available on the Investor Relations section of Constellation’s website at http://ir.constellationpharma.com/events-and-presentations/events.

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the 38th Annual J.P. Morgan Healthcare Conference in San Francisco.

Neovasc Inc. announced that it has closed its previously announced registered direct offering priced at-the-market under Nasdaq rules of an aggregate of 1,185,000 series A units and 1,241,490 series B units at a price of US$4.1351 per Series A Unit and US$4.135 per Series B Unit for aggregate gross proceeds to the Company of approximately US$10 million, before deducting placement agent’s fees and estimated expenses of the Offering payable by the Company.

Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company developing next-generation human enzyme therapeutics as solutions for diseases with high unmet medical need, announced it will present at the 38th Annual J.P. Morgan Healthcare Conference to be held January 13-16 in San Francisco, CA.

CRISPR Therapeutics announced that Samarth Kulkarni, Ph.D., Chief Executive Officer of CRISPR Therapeutics, is scheduled to present at the Goldman Sachs 12th Annual Healthcare CEOs Unscripted: A View from the Top conference on Thursday, January 9, 2020, at 1:10 p.m. ET.

Sensus Healthcare, Inc., a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces management promotions to better support the company’s financial goals for profitability in 2020 and beyond.

Neurocrine Biosciences, Inc. will present at the 38th Annual J.P. Morgan Healthcare Conference at 11:30 a.m. Pacific Time on Monday, Jan. 13, 2020, in San Francisco. Kevin Gorman, Chief Executive Officer, will present at the conference.

Arena Pharmaceuticals, Inc. will provide a corporate update highlighting its strategic portfolio expansion on a conference call tomorrow, January 7, at 9:00 AM ET, and provide additional detail at the 38th Annual J.P. Morgan Healthcare Conference taking place January 13-16, 2020.